Anzeige
+++Die USA starten den Quanten-Countdown!: Warum die Bankenwelt vor einem historischen Sicherheitsumbau steht+++
Portfolio Tracker
Dein Depot in Echtzeit – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
EQS-News

Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers 16.10.2026, 19:05 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: Angelalign Technology Inc. / Key word(s): Legal Matter/Patent
Paris Court Ruling on Discontinued Feature Will Have Minimal Impact on Angelalign Customers

16.10.2026 / 19:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


Angelalign Has Already Replaced Torque Ridges with Upgraded "Pressure Points" in Europe

SAN CLEMENTE, Calif., Oct. 16, 2026 /PRNewswire/ -- Angelalign Technology Inc. (6699.HK) ("Angel") http://www.angelaligner.com, a company driven by innovation in orthodontic clear aligner technology, said today that a ruling by the Paris Local Division of the Unified Patent Court concerning its Torque Ridges feature does not affect the availability of its offering in Europe, which already incorporates the next generation of torque-control technology. 

Angelalign Has Already Replaced Torque Ridges with Upgraded “Pressure Points” in Europe

Angel already has discontinued Torque Ridges in Europe and has replaced it with an upgraded feature called Pressure Points. Pressure Points, which launched in the European market in September, was designed to improve torque control and reflects Angel's continued commitment to innovation focused on solving orthodontists' clinical challenges. Angel customers in Spain, the UK and outside of Europe, including the Americas and Asia, are not affected by this ruling. Angel is constantly developing new solutions to continue to serve its customers well.

The court today ruled that the Torque Ridges feature infringes a patent held by Align Technology Inc. (ALGN) for repositioning a patient's teeth according to an orthodontic treatment plan. Angel respectfully disagrees with the decision and is reviewing it closely while it evaluates its options. Angel will comply with the court's ruling, including the return of any products. Because Torque Ridges is no longer offered in Europe, orthodontists using Angel products and services can continue treating their patients with access to Pressure Points and Angel's ongoing clinical and technical support.

"Our priority is to ensure that orthodontists can continue delivering excellent care to their patients," said Xavier Cherbavaz, General Manager and Vice President, Europe, Africa, and the Middle East, Angelalign Technology Inc. "Torque Ridges has already been retired in Europe and replaced with Pressure Points, an approach intended to support controlled force application and tooth contact. We remain focused on giving orthodontists innovative clinical solutions and a dependable customer experience."

"Angel takes intellectual property rights seriously and is careful not to infringe on valid patents," added Richard Hirschland, Angel's Chief Commercial Officer and SVP. "We are reviewing the court's reasoning carefully and will consider all available options. Angel will continue to innovate and improve its products to benefit its providers and their patients despite litigation by a competitor. Continuous innovation means anticipating challenges and preparing solutions to protect the customer experience. Our transition to Pressure Points reflects that commitment. We are determined to continue developing innovative solutions so that orthodontists can rely on Angel over the long term."

To learn more, visit angelaligner.com/eu and www.angelaligner.com.

About Angelalign Technology Inc.

Founded in 2003 and publicly listed since 2021, Angelalign Technology Inc. provides clear aligner solutions to clinically focused professionals and patients in over 60 countries. Having surpassed two million cumulative cases and with about a US$2 billion market capitalization, the company focuses on clinical innovation and professional support to help experts achieve extraordinary outcomes. Its established global operations and continued investment in innovation support its long-term commitment to orthodontists and their patients. Learn more at angelaligner.com.

Media Contact:

Sue Kolb
Angelalign Technology Inc.
sue.kolb@angelaligner.com

Angelalign Technology Inc., is a global provider of clear aligner technology with evidence based clinical expertise.  With over 20 years of experience and a commitment to research and digital innovation, Angelalign Technology Inc. has treated 1 million smiles, and is now expanding its expertise and global footprint.

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/paris-court-ruling-on-discontinued-feature-will-have-minimal-impact-on-angelalign-customers-302911488.html

rt.gif?NewsItemId=EN74308&Transmission_Id=202610161259PR_NEWS_EURO_ND__EN74308&DateId=20261016


16.10.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2417514  16.10.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer